Cargando…

Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel

Untargeted metabolomics is used to refine the development of biomarkers for the diagnosis of cardiovascular disease. Myocardial infarction (MI) has major individual and societal consequences for patients, who remain at high risk of secondary events, despite advances in pharmacological therapy. To mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samman, Karla N., Mehanna, Pamela, Takla, Emad, Grenier, Jean-Christophe, Chan, Mark Y., Lopes, Renato D., Neely, Megan Lee, Wang, Tracy Y., Newby, L. Kristin, Becker, Richard C., Lordkipanidzé, Marie, Ruiz, Matthieu, Hussin, Julie G., Jolicœur, E. Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233657/ https://www.ncbi.nlm.nih.gov/pubmed/34195679 http://dx.doi.org/10.1016/j.xcrm.2021.100299

Ejemplares similares

Ticagrelor as an Alternative for Clopidogrel-Associated Acute Arthritis
por: Bedy, Starr-Mar'ee C., et al.
Publicado: (2018)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
por: Volney, Candice, et al.
Publicado: (2019)

Hypersensitivity to ticagrelor and low response to clopidogrel: a case report
por: Dai, Jing, et al.
Publicado: (2017)

Safety of Ticagrelor Compared to Clopidogrel after Prehospital Initiation of Treatment
por: Bergmeijer, Thomas O., et al.
Publicado: (2018)

Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
por: Lomakin, Nikita, et al.
Publicado: (2019)

Temporal Variability of Platelet Reactivity in Patients Treated with Clopidogrel or Ticagrelor
por: Yun, Kyeong Ho, et al.
Publicado: (2019)

Comparison of ticagrelor and clopidogrel on platelet function and prognosis in unstable angina
por: Li, Chun, et al.
Publicado: (2022)

A Comparative Pharmacodynamic Study of Ticagrelor versus Clopidogrel and Ticagrelor in Patients Undergoing Primary Percutaneous Coronary Intervention: The CAPITAL RELOAD Study
por: Hibbert, Benjamin, et al.
Publicado: (2014)

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
por: YANG, Bin, et al.
Publicado: (2018)

Real‐World Comparison of Ticagrelor and Clopidogrel: Rosetta Stone or Lost in Translation?
por: Bergmark, Brian A.
Publicado: (2020)

Comparison of ticagrelor with clopidogrel on quality of life in patients with acute coronary syndrome
por: Moon, Hyeyeon, et al.
Publicado: (2021)

Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction
por: Scanavini-Filho, Marco Antonio, et al.
Publicado: (2022)

Aspirin/clopidogrel/ticagrelor: Diffuse ooze and bleeding: 2 case reports
Publicado: (2021)

Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement
por: Peasah, Samuel K., et al.
Publicado: (2023)

Optimal strategy of switching from clopidogrel to ticagrelor in Chinese acute coronary syndrome patients with complicated coronary artery disease: the switching from clopidogrel to ticagrelor (SHIFT-CACS) study
por: Yao, Ying, et al.
Publicado: (2019)

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study
por: Storey, Robert F., et al.
Publicado: (2014)

Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
por: Grima, Daniel T, et al.
Publicado: (2014)

Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting
por: Chang, Hyoung Woo, et al.
Publicado: (2019)

Effects of switching ticagrelor to clopidogrel on cardiovascular outcomes in patients with acute coronary syndrome
por: Liu, Lin, et al.
Publicado: (2018)

Effect of Ticagrelor Versus Clopidogrel on Aortic Stiffness in Patients With Coronary Artery Disease
por: Vlachopoulos, Charalambos, et al.
Publicado: (2019)

Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor
por: Carino, Annarita, et al.
Publicado: (2016)

Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA
por: Yang, Yingying, et al.
Publicado: (2020)

The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel
por: Choi, Woong Gil, et al.
Publicado: (2021)

Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel
por: Petousis, Stylianos, et al.
Publicado: (2022)

Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2023)

Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk
por: Tjerkaski, Jonathan, et al.
Publicado: (2023)

Randomized Trial Comparing the Effects of Ticagrelor Versus Clopidogrel on Myocardial Perfusion in Patients With Coronary Artery Disease
por: Pelletier‐Galarneau, Matthieu, et al.
Publicado: (2017)

Effects of switching ticagrelor to clopidogrel on cardiovascular outcomes in patients with acute coronary syndrome: Erratum
Publicado: (2018)

Clinical safety profile of ticagrelor compared to clopidogrel in 1208 patients: Real world evidence
por: Kumar, Viveka, et al.
Publicado: (2018)

Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis
por: Wang, Dong, et al.
Publicado: (2018)

Time-based measures of treatment effect: reassessment of ticagrelor and clopidogrel from the PLATO trial
por: Bellavia, Andrea, et al.
Publicado: (2017)

Comparison of atrial fibrillation predictors in patients with acute coronary syndrome using ticagrelor or clopidogrel
por: ALGÜL, Engin, et al.
Publicado: (2019)

Clinical Outcome between Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome and Diabetes
por: He, Peixun, et al.
Publicado: (2021)

Ticagrelor Versus Clopidogrel in East Asian Patients With Acute Coronary Syndrome and Diabetes Mellitus
por: Choi, Yeonwoo, et al.
Publicado: (2022)

Ticagrelor versus clopidogrel after intracranial stent angioplasty: a real-world study
por: Sun, Lili, et al.
Publicado: (2023)

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndrome and on Dialysis: A Meta-Analysis
por: Chenna, Venkata Sai Harshabhargav, et al.
Publicado: (2023)

Impact of concomitant use of proton pump inhibitors and clopidogrel or ticagrelor on clinical outcomes in patients with acute coronary syndrome
por: Yan, Yan, et al.
Publicado: (2016)

Efficacy and safety outcomes of ticagrelor compared with clopidogrel in elderly Chinese patients with acute coronary syndrome
por: Wang, Huidong, et al.
Publicado: (2016)

Anti-platelet effects of epigallocatechin-3-gallate in addition to the concomitant aspirin, clopidogrel or ticagrelor treatment
por: Joo, Hyung Joon, et al.
Publicado: (2018)

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
por: Krishnamurthy, Arvindra, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sago8v0l40cpsu7dlkr3oeh2ue